Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targets.
Identifying novel therapeutic targets for the treatment of disease is challenging. To this end, we developed a genome-wide approach of candidate gene prioritization. We independently collocated sets of genes that were implicated in rheumatoid arthritis (RA) pathogenicity through three genome-wide as...
Main Authors: | John W Whitaker, David L Boyle, Beatrix Bartok, Scott T Ball, Steffen Gay, Wei Wang, Gary S Firestein |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4406750?pdf=render |
Similar Items
-
Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets.
by: John W Whitaker, et al.
Published: (2015-01-01) -
Nutrition and Rheumatoid Arthritis in the ‘Omics’ Era
by: Manuela Cassotta, et al.
Published: (2021-02-01) -
Distinct DNA Methylation Patterns of Rheumatoid Arthritis Peripheral Blood and Synovial Tissue T Cells
by: Rizi Ai, et al.
Published: (2021-03-01) -
Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes
by: Rizi Ai, et al.
Published: (2016-06-01) -
The not obvious obviousness…
by: Konarski Maciej
Published: (2018-12-01)